Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation
Alexander Nikoloudis(Johannes Kepler University of Linz), Johannes Clausen(Johannes Kepler University of Linz), Sigrid Machherndl‐Spandl(Krankenhaus der Elisabethinen), Christoph Aichinger(Krankenhaus der Elisabethinen), Andreas Petzer(Ordensklinikum Linz Barmherzige Schwestern), Emine Kaynak(Krankenhaus der Elisabethinen), Dominik Wolf(Universität Innsbruck), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), David Nachbaur(Innsbruck Medical University), Robert Milanov(Krankenhaus der Elisabethinen), Michaela Binder(Durham University), Irene Straßl(Krankenhaus der Elisabethinen), Dagmar Wipplinger(Krankenhaus der Elisabethinen), Alexandra Böhm(Krankenhaus der Elisabethinen), Ansgar Weltermann, Olga Stiefel(Krankenhaus der Elisabethinen)
Cited by 3
Related Papers
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|764
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523